Immunogenicity 15729
Sample ID
CGLU116
Response
Positive
Tumor Type
Lung cancer
Gene Symbol
SLC26A7
Transcript ID
None
HLA INFO
C*15:02
TCR INFO
No TCR info found!
Full length protein sequence (663 aa)
MTGAK
1
RKKKS
6
MLWSK
11
MHTPQ
16
CEDII
21
QWCRR
26
RLPIL
31
DWAPH
36
YNLKE
41
NLLPD
46
TVSGI
51
MLAVQ
56
QVTQG
61
LAFAV
66
LSSVH
71
PVFGL
76
YGSLF
81
PAIIY
86
AIFGM
91
GHHVA
96
TGTFA
101
LTSLI
106
SANAV
111
ERIVP
116
QNMQN
121
LTTQS
126
NTSVL
131
GLSDF
136
EMQRI
141
HVAAA
146
VSFLG
151
GVIQV
156
AMFVL
161
QLGSA
166
TFVVT
171
EPVIS
176
AMTTG
181
AATHV
186
VTSQV
191
KYLLG
196
MKMPY
201
ISGPL
206
GFFYI
211
YAYVF
216
ENIKS
221
VRLEA
226
LLLSL
231
LSIVV
236
LVLVK
241
ELNEQ
246
FKRKI
251
KVVLP
256
VDLVL
261
IIAAS
266
FACYC
271
TNMEN
276
TYGLE
281
VVGHI
286
PQGIP
291
SPRAP
296
PMNIL
301
SAVIT
306
EAFGV
311
ALVGY
316
VASLA
321
LAQGS
326
AKKFK
331
YSIDD
336
NQEFL
341
AHGLS
346
NIVSS
351
FFFCI
356
PSAAA
361
MGRTA
366
GLYST
371
GAKTQ
376
VACLI
381
SCIFV
386
LIVIY
391
AIGPL
396
LYWLP
401
MCVLA
406
SIIVV
411
GLKGM
416
LIQFR
421
DLKKY
426
WNVDK
431
IDWGI
436
WVSTY
441
VFTIC
446
FAANV
451
GLLFG
456
VVCTI
461
AIVIG
466
RFPRA
471
MTVSI
476
KNMKE
481
MEFKV
486
KTEMD
491
SETLQ
496
QVKII
501
SINNP
506
LVFLN
511
AKKFY
516
TDLMN
521
MIQKE
526
NACNQ
531
PLDDI
536
SKCEQ
541
NTLLN
546
SLSNG
551
NCNEE
556
ASQSC
561
PNEKC
566
YLILD
571
CSGFT
576
FFDYS
581
GVSML
586
VEVYM
591
DCKGR
596
SVDVL
601
LAHCT
606
ASLIK
611
AMTYY
616
GNLDS
621
EKPIF
626
FESVS
631
AAISH
636
IHSNK
641
ASYKL
646
LFDNL
651
DLPTM
656
PPL
661
Mutation Information
DNA mutation:
None
Peptide Range:
110 ~ 119
Mut AA position:
117 (8 in Wild Type peptide)
Alignment
Wild Type:
"ISANAVERIV
|||||||.||
Mutant:
ISANAVEQIV"
Cancer Discov, 2017
Evolution of Neoantigen Landscape during Immune Checkpoint Blockade in Non-small Cell Lung CancerGene Name (from Reference) SLC26A7
Checkpoint
Blockade
nivolumab/ipilimumab
ACT
N
Vaccination
N
Curative
Effect
partial response
minimal_peptide
Y
Antigen
Type
peptide
T-cell
Source
PBMCs
APC
Type
None
Assay
None